'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
'Top drawer IP set.'
Legal 500 2010
'clerking team that exhibits 'perfect communication''
Legal 500 2008
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
'outstanding IP chambers'
Legal 500 2008
'8 New Square successfully parlays its renowned IP expertise into success in the IT sector.'
Chambers & Partners (Information Technology) 2009
'An incredibly good set for IP matters'.
Legal 500 2010
'A number of great IT and telecoms barristers.'
Legal 500 2010
'excellence on IT matters'
Legal 500 (Information Technology) 2010
Eli Lilly & Co v Human Genome Sciences Inc [2011] UKSC 51
Case Summary | Judgment | 2 November 2011
Michael Tappin QC acted for Human Genome Sciences before the Supreme Court and the Court of Appeal in its litigation against Eli Lilly concerning HGS' patent relating to Neutrokine-α (and antibodies thereto). Kitchin J had held the patent invalid for lack of industrial applicability. The Court of Appeal ([2010] EWCA Civ 33) upheld the judgment of Kitchin J, but the Supreme Court reversed those decisions and held that the inventions were capable of industrial application ([2011] UKSC 51). This case is the first in which the UK courts have had to give serious consideration to the law on industrial application, and the first patent case to reach the Supreme Court since its creation.